One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias.

Objectives: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.

Methods: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline.